“⌛텔문의2만지급 토토오톡티비.COM 소닉티비⌛”的搜索结果，显示 21-30 项，共有 10992 项

1. 神经科- 临床试验- 妙佑医疗国际

   The purpose of phase 2 of this trial is to evaluate the effectiveness of sequentially administering temozolomide and selinexor in recurrent glioblastoma as ...

2. 乳腺专科门诊- 临床试验- 妙佑医疗国际

   Scottsdale/Phoenix, Ariz. This phase II trial tests whether an exercise intervention works to improve cognitive function in breast cancer survivors. Many breast ...

3. 乳腺专科门诊- 临床试验- 妙佑医疗国际

   This is a phase 1b/2 study of the safety and efficacy of MLN0128 in combination with exemestane or fulvestrant therapy in women with estrogen receptor positive/ ...

4. 神经科- 临床试验- 妙佑医疗国际

   The purpose of phase 2 of this trial is to evaluate the effectiveness of sequentially administering temozolomide and selinexor in recurrent glioblastoma as ...

5. 精神病与心理科- 临床试验- 妙佑医疗国际

   and/or disease duration, and whether there is a left-right difference in the density of a-syn pathology. Specific Aim 2. Determine, with a second SMG biopsy in ...

6. 神经科- 临床试验- 妙佑医疗国际

   The purpose of phase 2 of this trial is to evaluate the effectiveness of sequentially administering temozolomide and selinexor in recurrent glioblastoma as ...

7. 神经科- 临床试验- 妙佑医疗国际

   This randomized phase III trial compares memantine hydrochloride and whole-brain radiotherapy with or without hippocampal avoidance in reducing ...

8. 肾上腺癌- 医生与科室- 妙佑医疗国际

   了解这种起源于肾上腺的罕见癌症，以及其症状、诊断和治疗（包括肾上腺切除术）。

9. 血液科- 临床试验- 妙佑医疗国际

   Patients randomized to B+R will receive 6 cycles of treatment consisting of a rituximab infusion (Cycle 1: 375 mg/m2; Cycles 2-6: 500 mg/m2) on Day 1 and ...

10. 乳腺专科门诊- 临床试验- 妙佑医疗国际

    The primary aim of this study is to determine if the addition of an individual polygenic risk score (PRS) in addition to the Breast Cancer Risk Assessment ...